MDU Resources Group, Inc. (NYSE:MDU) today announced that Nicole Kivisto
has been named president and CEO of the corporation’s utility group,
which includes Montana-Dakota Utilities Co., Great Plains Natural Gas
Co., Cascade Natural Gas Corp.
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced
today that its partner Melinta Therapeutics reported positive top-line
results from the first of two Phase 3 PROCEED studies (study
RX-3341-302, NCT01811732) to evaluate delafloxacin, an investigational
fluoroquinolone, compared with vancomycin + aztreonam for the treatment
of patients with acute bacterial skin and skin structure infections
(ABSSSI). Delafloxacin met the study’s primary objective endpoint of a
reduction in the measurement of lesion erythema at the primary infection
site at 48- to- 72 hours, the endpoint required by the U.S. Food and
Drug Administration (FDA). Delafloxacin also was comparable to
vancomycin in the study’s secondary endpoints, including investigator
assessment of signs and symptoms of infection at the follow-up visit, a
metric required by the European Medicines Agency (EMA).
- 4Q14 Ocean Transportation operating income expected to be approximately $45.0 million - Preliminary full year 2015 outlook: -- Ocean Transportation operating income expected to be flat to modestly higher than 2014 levels
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.